Xella Health

Xella Health is a private women’s precision health and telemedicine company focused on earlier detection and management of conditions that uniquely, disproportionately, or differently affect women. The company combines multi-omic biomarker testing, clinical questionnaires, AI-driven risk profiling, and clinician-guided care to help users identify potential root causes of symptoms across fertility, hormonal health, chronic gynecologic conditions, and cancer risk. Its commercial membership platform launched in June 2026 and is marketed as available across most U.S. states, with blood-draw testing through partner labs and ongoing personalized care. Rather than developing therapeutic drugs, Xella operates as a diagnostics-enabled digital health platform intended to improve diagnostic accuracy, longitudinal monitoring, and care navigation in women’s health.